3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Dermatologic
1
Breast
1
Conditions
Breast Neoplasms
12
Motor Activity
5
Colorectal Neoplasms
5
Neoplasms
4
Smoking Cessation
3
Endometrial Neoplasms
3
Uterine Cervical Neoplasms
2
Smoking
2
Prostatic Neoplasms
2
Papillomavirus Infections
2
Lung Neoplasms
2
Colonic Neoplasms
2
Behavior
2
Skin Cancer Prevention
1
Polycystic Ovary Syndrome
1
Patient Compliance
1
Pancreatic Neoplasms
1
Overweight
1
Ovarian Neoplasms
1
Other Cancer
1
Obesity
1
Melanoma
1
Lymphedema
1
Gastrointestinal Neoplasms
1
Colorectal Cancer Screening
1
Chronic Pain
1
Body Weight Changes
1
Body Weight
1
Anxiety Disorders
1
Interventions
Surveys and Questionnaires
9
Standard of Care
5
Endoscopic Mucosal Resection
5
Educational Status
5
Blood Specimen Collection
5
Diet Therapy
3
Referral and Consultation
2
Quality of Life
2
Practice Guidelines as Topic
2
Palliative Care
2
Magnetic Resonance Spectroscopy
2
Interviews as Topic
2
Control Groups
2
Aprepitant
2
Acceptance and Commitment Therapy
2
vandetanib
1
fosaprepitant
1
dolasetron
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
auricularum
1
Weights and Measures
1
Tomography, X-Ray Computed
1
Therapeutics
1
Surgical Instruments
1
Sunitinib
1
Sorafenib
1
Sampling Studies
1
Restraint, Physical
1
Remote Patient Monitoring
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Gastrointestinal Neoplasms
×
Motivational Interviewing
×
Clear all
NCT04899492
2024-11-07
RESPIRE
Institut Cancerologie de l'Ouest
Phase NA
Terminated
22 enrolled